FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Approves Tevas Generic Seizure Drug

FDA approves a Teva Pharmaceuticals ANDA for the first generic version of Lundbecks Sabril (vigabatrin) 500 mg tablets for treating complex partial se...

Human Drugs

Rare Diseases Drug Development Draft Guidance

FDA issues a revised draft guidance on common issues in drug development for rare diseases.

Medical Devices

FDA Clears Immuno Concepts LKS Tissue Slides

FDA clears an Immuno Concepts 510(k) for the Histofluor Rodent LKS Tissue Slides for manual and Image Navigator use.

Medical Devices

AdvaMed Updates Ethics Code

AdvaMed says updates to its code of ethics on interactions with healthcare professionals will take effect next 1/1.

Human Drugs

Contepo PDUFA Date Accelerated

FDA accelerates by two months the PDUFA review date for Nabriva Therapeutics Contepo antibiotic.

FDA General

400 Unpaid FDAers Come Back to Conduct Inspections

FDA orders about 400 inspectors and support professionals to return to their posts from furlough to re-initiate high-risk surveillance inspections acr...

Biologics

Advancing Cell and Gene Therapy Development

FDA commissioner Scott Gottlieb looks at ways the agency is coping with an upswing in cell and gene therapy INDs.

Human Drugs

Azar Sees Drug Price Progress

HHS secretary Alex Azar says progress is being made in reducing drug costs to consumers.

Human Drugs

Menlo Gains Breakthrough Status for Pruritus Therapy

FDA grants Menlo Therapeutics a breakthrough therapy designation for serlopitant for treating pruritus associated with prurigo nodularis.

Human Drugs

Firm Paid $2.5 million User Fee for Non-reviewed BLA

Aimmune Therapeutics mistakingly pays a $2.5 million user fee with a BLA submission for AR101, an investigational biologic oral immunotherapy for trea...